BridgeMD
New treatment option for Pancreatic Cancer
Official title A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice
ClinicalTrials.gov ID: NCT06541340
What this study is testing
- What it's testing
- Severe obstructive jaundice caused by pancreatic head cancer usually requires preoperative biliary drainage, but its necessity and effectiveness are controversial, and specific strategies lack clear standards. This study proposed a new strategy for preoperative biliary drainage using serum prealbumin as the main evaluation index, and compared it with the traditional strategy using serum total bilirubin as the main evaluation index.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Pathological diagnosis of pancreatic head cancer, or clinical diagnosis of pancreatic head cancer after multidisciplinary discussion, clear presence...
- Preoperative imaging stage is resectable
- Baseline serum total bilirubin ≥ 250μmol/L, and no history of preoperative biliary drainage
- Age \>18 and ≤75 years old
- ECOG(Eastern Cooperative Oncology Group) physical score ≤ 2
You likely can't join if
- Combined with other malignant tumors
- Combined with uncontrolled medical diseases or organ dysfunction and other absolute counterindications for surgery
- Pregnant and lactating women
- Patients who cannot tolerate preoperative biliary drainage or radical surgery
- Other situations that are not suitable for inclusion in clinical trials
See the full eligibility criteria
- Pathological diagnosis of pancreatic head cancer, or clinical diagnosis of pancreatic head cancer after multidisciplinary discussion, clear presence of obstructive jaundice caused by pancreatic head tumor, and planned...
- Preoperative imaging stage is resectable
- Baseline serum total bilirubin ≥ 250μmol/L, and no history of preoperative biliary drainage
- Age \>18 and ≤75 years old
- ECOG(Eastern Cooperative Oncology Group) physical score ≤ 2
- Signed informed consent, received preoperative endoscopic biliary drainage (ERCP) and radical surgery timing evaluation
- Combined with other malignant tumors
- Combined with uncontrolled medical diseases or organ dysfunction and other absolute counterindications for surgery
- Pregnant and lactating women
- Patients who cannot tolerate preoperative biliary drainage or radical surgery
- Other situations that are not suitable for inclusion in clinical trials
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.